Neurol. praxi. 2025;26(2):163-168 | DOI: 10.36290/neu.2025.040

Modifiable risk factors for dementia

RNDr. Mgr. Kateřina Veverová, Ph.D.1, 2, MUDr. Julie Martínková Nováková1, MUDr. Juraj Sečník, Ph.D.1, MUDr. Jakub Šteiner1, MUDr. Simona Karamazovová1, Mgr. Zuzana Chmátalová, Ph.D.3, MUDr. Ondřej Lerch, Ph.D.1
1 Neurologická klinika 2. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice v Motole, Praha
2 Katedra psychologie Filozofické fakulty Univerzity Karlovy, Praha
3 Ústav lékařské chemie a klinické biochemie 2. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice v Motole, Praha

The number of dementia cases is increasing globally. Currently, more than 55 million people worldwide are living with dementia, and according to the World Health Organization, this number is expected to more than double in the next 30 years. Dementia thus represents a significant global health challenge. The 2024 Lancet Commission report identified 14 modifiable risk factors, the elimination of which could potentially prevent up to 45 % of dementia cases. These key risk factors include low education, hearing loss, high LDL cholesterol, depression, traumatic brain injury, physical inactivity, diabetes, smoking, hypertension, obesity, excessive alcohol consumption, social isolation, air pollution, and untreated vision loss. The relevance of individual risk factors varies across the lifespan; however, early intervention can significantly reduce the risk of developing dementia. The identification and targeted intervention of modifiable risk factors should be a priority in both individual clinical practice and public health strategies.

Keywords: cognitive impairment, dementia, modifiable risk factors, prevention.

Received: April 16, 2025; Revised: April 16, 2025; Accepted: April 22, 2025; Prepublished online: April 22, 2025; Published: May 5, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Veverová K, Martínková Nováková J, Sečník J, Šteiner J, Karamazovová S, Chmátalová Z, Lerch O. Modifiable risk factors for dementia. Neurol. praxi. 2025;26(2):163-168. doi: 10.36290/neu.2025.040.
Download citation

References

  1. Cohen AJ, Brauer M, Burnett R, et al. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: An analysis of data from the Global Burden of Diseases Study 2015. The Lancet. 2017;389(10082):1907-1918. https://doi.org/10.1016/S0140-6736(17)30505-6. Go to original source... Go to PubMed...
  2. Daviet R, Aydogan G, Jagannathan K, et al. Associations between alcohol consumption and gray and white matter volumes in the UK Biobank. Nature Communications. 2022;13(1):1175. https://doi.org/10.1038/s41467-022-28735-5. Go to original source... Go to PubMed...
  3. Fang M, Hu J, Weiss J, et al. Lifetime risk and projected burden of dementia. Nature Medicine. 2025;1-5. https://doi.org/10.1038/s41591-024-03340-9. Go to original source... Go to PubMed...
  4. Farina FR, Bridgeman K, Gregory S, et al. Next generation brain health: Transforming global research and public health to promote prevention of dementia and reduce its risk in young adult populations. The Lancet Healthy Longevity. 2024; 0(0). https://doi.org/10.1016/j.lanhl.2024.100665. Go to original source... Go to PubMed...
  5. Fortea J, Pegueroles J, Alcolea D, et al. APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease. Nature Medicine. 2024;30(5):1284-1291. https://doi.org/10.1038/s41591-024-02931-w. Go to original source... Go to PubMed...
  6. Graham NS, Sharp DJ. Understanding neurodegeneration after traumatic brain injury: From mechanisms to clinical trials in dementia. Journal of Neurology, Neurosurgery & Psychiatry. 2019;90(11):1221-1233. https://doi.org/10.1136/jnnp-2017-317557. Go to original source... Go to PubMed...
  7. Grande G, Ljungman P, Eneroth K, et al. Long-term Exposure to Air Pollution and the Risk of Dementia: The Role of Cardiovascular Disease (1839). Neurology. 2020;94(15_supplement):1839. https://doi.org/10.1212/WNL.94.15_supplement.1839. Go to original source...
  8. Griffiths TD, Lad M, Kumar S, et al. How Can Hearing Loss Cause Dementia? Neuron. 2020;108(3):401-412. https://doi.org/10.1016/j.neuron.2020.08.003. Go to original source... Go to PubMed...
  9. Huuha AM, Norevik CS, Moreira JBN, et al. Can exercise training teach us how to treat Alzheimer's disease? Ageing Research Reviews. 2022;75:101559. https://doi.org/10.1016/j.arr.2022.101559. Go to original source... Go to PubMed...
  10. Iso-Markku P, Kujala UM, Knittle K, et al. Physical activity as a protective factor for dementia and Alzheimer's disease: Systematic review, meta-analysis and quality assessment of cohort and case-control studies. British Journal of Sports Medicine. 2022;56(12):701-709. https://doi.org/10.1136/bjsports-2021-104981. Go to original source... Go to PubMed...
  11. Kivimäki M, Walker K, Pentti J, et al. Cognitive stimulation in the workplace, plasma proteins, and risk of dementia: Three analyses of population cohort studies. BMJ. 2021;374:n1804. https://doi.org/10.1136/bmj.n1804. Go to original source... Go to PubMed...
  12. Knopman DS, Amieva H, Petersen RC, et al. Alzheimer disease. Nature Reviews Disease Primers. 2021;7(1):1-21. https://doi.org/10.1038/s41572-021-00269-y. Go to original source... Go to PubMed...
  13. Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet. 2024;404(10452):572-628. https://doi.org/10.1016/S0140-6736(24)01296-0. Go to original source... Go to PubMed...
  14. Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive summary: Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010;121(7):948-954. https://doi.org/10.1161/CIRCULATIONAHA.109.192666. Go to original source... Go to PubMed...
  15. Ma H, Li X, Zhou T, et al. Alcohol Consumption Levels as Compared With Drinking Habits in Predicting All-Cause Mortality and Cause-Specific Mortality in Current Drinkers. Mayo Clinic Proceedings. 2021;96(7):1758-1769. https://doi.org/10.1016/j.mayocp.2021.02.011. Go to original source... Go to PubMed...
  16. Matuskova V, Ismail Z, Nikolai T, et al. Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort. Frontiers in Aging Neuroscience. 2021;13. https://doi.org/10.3389/fnagi.2021.643271. Go to original source... Go to PubMed...
  17. Mena MP, Sacanella, E, Vazquez-Agell M, et al. Inhibition of circulating immune cell activation: A molecular antiinflammatory effect of the Mediterranean diet. The American Journal of Clinical Nutrition. 2009;89(1):248-256. https://doi.org/10.3945/ajcn.2008.26094. Go to original source... Go to PubMed...
  18. Mohamed AZ, Nestor PJ, Cumming P, et al., & Alzheimer's Disease Neuroimaging Initiative. Traumatic brain injury fast-forwards Alzheimer's pathology: Evidence from amyloid positron emission tomorgraphy imaging. Journal of Neurology. 2022;269(2):873884. https://doi.org/10.1007/s00415-021-10669-5. Go to original source... Go to PubMed...
  19. Nichols E, Merrick R, Hay SI, et al. The prevalence, correlation, and co-occurrence of neuropathology in old age: Harmonisation of 12 measures across six community-based autopsy studies of dementia. The Lancet. Healthy Longevity. 2023;4(3):e115-e125. https://doi.org/10.1016/S2666-7568(23)00019-3. Go to original source... Go to PubMed...
  20. Schaffert J, LoBue C, White CL, et al. Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology. 2018;32(4):410-416. https://doi.org/10.1037/neu0000423. Go to original source... Go to PubMed...
  21. Shannon OM, Ranson JM, Gregory S, et al. Mediterranean diet adherence is associated with lower dementia risk, independent of genetic predisposition: Findings from the UK Biobank prospective cohort study. BMC Medicin. 2023;21(1):81. https://doi.org/10.1186/s12916-023-02772-3. Go to original source... Go to PubMed...
  22. Sims JR, Zimmer JA, Evans CD, et al., & TRAILBLAZER-ALZ 2 Investigators. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA. 2023;330(6):512-527. https://doi.org/10.1001/jama.2023.13239. Go to original source... Go to PubMed...
  23. Sommerlad A, Kivimäki M, Larson EB, et al. Social participation and risk of developing dementia. Nature Aging. 2023;3(5):532-545. https://doi.org/10.1038/s43587-023-00387-0. Go to original source... Go to PubMed...
  24. van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in Early Alzheimer's Disease. The New England Journal of Medicine. 2023;388(1):9-21. https://doi.org/10.1056/NEJMoa2212948. Go to original source... Go to PubMed...
  25. Villemagne VL, Burnham S, Bourgeat P, et al. & Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: A prospective cohort study. The Lancet. Neurology. 2013;12(4):357-367. https://doi.org/10.1016/S1474-4422(13)70044-9. Go to original source... Go to PubMed...
  26. Voronina TA. Cognitive Impairment and Nootropic Drugs: Mechanism of Action and Spectrum of Effects. Neurochemical Journal. 2023;17(2):180-188. https://doi.org/10.1134/S1819712423020198. Go to original source...
  27. Yang L, Deng YT, Leng Y, Depression, Depression Treatments, and Risk of Incident Dementia: A Prospective Cohort Study of 354,313 Participants. Biological Psychiatry. 2023;93(9):802-809. https://doi.org/10.1016/j.biopsych.2022.08.026. Go to original source... Go to PubMed...
  28. Yeo BSY, Song HJJMD, Toh EMS, et al. Association of Hearing Aids and Cochlear Implants With Cognitive Decline and Dementia: A Systematic Review and Meta-analysis. JAMA Neurology. 2023;80(2):134-141. https://doi.org/10.1001/jamaneurol.2022.4427. Go to original source... Go to PubMed...
  29. Yu RC, Proctor D, Soni J, et al. Adult-onset hearing loss and incident cognitive impairment and dementia - a systematic review and meta-analysis of cohort studies. Ageing Research Reviews. 2024;98:102346. https://doi.org/10.1016/j.arr.2024.102346. Go to original source... Go to PubMed...
  30. Zhang B, Weuve J, Langa KM, et al. Comparison of Particulate Air Pollution From Different Emission Sources and Incident Dementia in the US. JAMA Internal Medicine. 2023;183(10):1080-1089. https://doi.org/10.1001/jamainternmed.2023.3300. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.